Reverie Labs Is A Biotechnology Company Based In Cambridgemassachusettsfounded In 2017The Company Specializes In Ai Driven Drug Discoveryfocusing On Developing Brain Penetrant Cancer Therapiesreverie Employs Advanced Techniques Such As Computational Chemistrymachine Learningand Evolutionary Algorithms To Enhance Preclinical Drug Developmentparticularly For Kinase Inhibitors That Address Unmet Patient Needs The Company Develops Structure Based Predictive Models For Small Molecule Potency And Pharmacokineticsalongside Custom Models Tailored To Partner Datasetsreverie Also Utilizes Multi Objective Molecular Optimization To Design Molecules That Balance Potencysynthesizabilityand Pharmacokinetic Propertiesin February 2024Reverie S Ai Platform Infrastructure And Software Were Acquired By Ginkgo Bioworkswhich Integrated Members Of Reverie S Ai Team To Bolster Its Drug Discovery Efforts
